Immutable X price prediction: Downward momentum persists while support at $0.0495 remains crucial
Immutable X (IMX) is trading at $0.0887, down 7.6% on the day. The asset is currently positioned below its key moving averages, reflecting continued near-term and broader weakness.
Highlights
- IMX/USD trades below key short- and long-term moving averages, confirming sustained downside pressure in the current market setup.
- Momentum indicators deliver clear sell signals, with the market oversold but lacking confirmation of any imminent reversal.
- Expected trading range for the next 1 to 3 days is $0.0495 to $0.0919 with high probability of further decline.
Technicals signal entrenched selling amid oversold momentum
IMX remains below H1 SMA-20 at $0.0936, H1 SMA-50 at $0.0952, and well under the long-term D1 SMA-200 at $0.1393. Ichimoku Kijun on the hourly is observed at $0.093, currently acting as a resistance level. Momentum readings indicate persistent weakness as both MACD and ADX continue to show sell signals. RSI, Stoch RSI, and CCI all register in oversold territory, highlighting downside exhaustion but not confirming a reversal. Bull/Bear Power remains negative, reflecting a dominance of sellers on the intraday scale.
Limited rebound prospects as downside risk dominates outlook
For the coming 1 to 3 days, IMX is expected to trade within the $0.0495 to $0.0919 range, a volatility band relative to current levels. The likelihood of a short-term rebound is low, given the persistent downward momentum. If price breaks above $0.093, it could signal the start of a corrective bounce, but sustained selling would keep the bias lower. A decisive move below $0.0495 would confirm downside extension and reinforce the prevailing bearish scenario.
Earlier, analysts noted that Immutable X was under sustained selling pressure, with technical readings supporting a bearish outlook. The latest price action and momentum signals reinforce this view, with traders advised to monitor for a decisive move below $0.0495 as confirmation of further downside risk.